A Phase 2b, Randomized, Controlled Trial Evaluating GS-5

Project: Research project

Project Details

Description

A Phase 2b, Randomized, Controlled Trial Evaluating GS-5806 in Lung Transplant (LT) Recipients with Respiratory Syncytial Virus (RSV) Infection
StatusFinished
Effective start/end date7/14/1512/31/17

Funding

  • Gilead Sciences, Inc.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.